gtu-multhiv b vaccine

Vaccineexperimental

Clinical trial activity

6 trials · 13 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2009 (NCT01130376)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • gtu-multhiv b vaccine
  • gtu-multihiv b clade
  • gtu-multihiv b clade vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02972450Phase 2Feb 1, 2017European Commission, FIT Biotech Ltd., French National Agency for Research on AIDS and Viral Hepatitis, Government of Switzerland, Institut National de la Santé Et de la Recherche Médicale, France, Istituto Nazionale Malattie Infettive Lazaro Spallanzani, Medical Research Council, University of Hamburg, University of Lausanne, University of London, University of Washington
NCT02457689Phase 1/Phase 2 (Phase 2)Jul 1, 2015European Commission, Medical Research Council, University of London
NCT02038842Phase 1/Phase 2 (Phase 2)Mar 1, 2014CHU Henri Mondor, French National Agency for Research on AIDS and Viral Hepatitis
NCT01492985Phase 2Jul 1, 2013French National Agency for Research on AIDS and Viral Hepatitis
NCT02075983Phase 1Jun 1, 2013Cordis, University of London
NCT01130376Phase 1Sep 1, 2009Medical Research Council, University of London
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (13)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of LondonAcademic/Hospital4322009
French National Agency for Research on AIDS and Viral HepatitisGovernment3312013
Medical Research CouncilGovernment3022009
European CommissionGovernment2012015
CHU Henri MondorAcademic/Hospital1012014
CordisFor profit1012013
FIT Biotech Ltd.For profit1012017
Government of SwitzerlandGovernment1012017
Institut National de la Santé Et de la Recherche Médicale, FranceAcademic/Hospital1012017
Istituto Nazionale Malattie Infettive Lazaro SpallanzaniAcademic/Hospital1012017
University of HamburgAcademic/Hospital1012017
University of LausanneAcademic/Hospital1012017
University of WashingtonAcademic/Hospital1012017
13 organizations
Page 1 / 1